Medical and Pharmaceutical Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug The authorization could help facilitate significant revenue growth Rowan DunneApril 12, 2026
Health & Wellness BeOne Medicines gets positive stock bump on RBC Capital upgrade Analysts see strong upside potential in BeOne’s move into solid tumours Joseph MortonJuly 16, 2025